VII Encuentro Farma-Biotech, en el área de oncología
Fechas
Vie, 21/09/2012
Descripción
VII Encuentro Farma-Biotech, en el área de oncología, que se celebró en BioSpain 2012 el pasado 21 de septiembre en Bilbao.
Inscripciones
Ciudad
Bilbao
Dirección
Bilbao Exhibition Centre, Ronda de Azkue 1.
Presentaciones y Documentación
- 09:30- 10:00 IKH02: Inhibitor of HDAC as monotherapy for liver cancer. The preclinical regulatory validation phase has been finished. (Eider San Sebastián IKERCHEM, SL )
- 10:00-10:30 New drugs against invasive tumors in breast and pancreas, from the human protein Cystatin-(C. Myriam Fabré ONCOMATRIX, SL)
- 10:30-11:00 APDD01: New drug for oral administration that can focus on several tumors. The preclinical regulatory validation phase has been started. -(Simó Swarch ARGON PHARMA, SL)
- 11:30- 12:00 EC 70124: Inhibitor of NF-kB route, which attacks the tumor stem cells. The preclinical regulatory validation phase has been started. -(Francisco Morís ENTRECHEM, SL)
- 12:00- 12:30 Ab anti-ephrinB2: New therapy looked at inhibiting angiogenesis. Transfer from research done in the Spanish National Cancer Research Centre. -(Damiá Tormo BIONCOTECH, SL)
- 12:30- 13:00 LK1: Selective antagonist exclusive of Integrin avb3. Transfer from research done in Leitat Technological Center. -( Francesc Mitjans LIKERA BIOMED, SA)
